"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
(Generic versions may still be available.)
Sodium hyaluronate is a high molecular weight polysaccharide, composed of sodium, glucuronate and N-acetyl-glucosamine which forms a repeating disaccharide unit by linking alternately beta 1-3 and beta 1-4 glycosidic bonds. The 1% viscous and transparent material, PROVISC, is a specific fraction of sodium hyaluronate, developed as an aid in ophthalmic surgery. It acts as a space occupying fluid that is replaced by the body†?s natural fluids.
Last reviewed on RxList: 2/15/2005
This monograph has been modified to include the generic and brand name in many instances.
Additional Provisc Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.